Ilias Ettayebi
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion.
Journal: Cancer discovery
Published: January 17, 2024
Ratio of stemness to interferon signalling as a biomarker and therapeutic target of myeloproliferative neoplasm progression to acute myeloid leukaemia.
Journal: British journal of haematology
Published: May 02, 2023
Inhibiting EZH2 targets atypical teratoid rhabdoid tumor by triggering viral mimicry via both RNA and DNA sensing pathways.
Journal: Nature communications
Published: March 01, 2023
An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors.
Journal: Journal for immunotherapy of cancer
Published: June 23, 2020
DNA hypomethylating agents increase activation and cytolytic activity of CD8+ T cells.
Journal: Molecular cell
Published: June 12, 2020
Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependency.
Journal: Nature
Published: February 06, 2020
Epigenetic Switch-Induced Viral Mimicry Evasion in Chemotherapy-Resistant Breast Cancer.
Journal: Cancer discovery
Published: December 17, 2019
Methods to detect endogenous dsRNA induction and recognition.
Journal: Methods in enzymology
Published: November 16, 2019
The Cancer Epigenome: Exploiting Its Vulnerabilities for Immunotherapy.
Journal: Trends in cell biology
Published: June 14, 2018
Sensitive tumour detection and classification using plasma cell-free DNA methylomes.
Journal: Nature
Published: December 05, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026